107 related articles for article (PubMed ID: 16445828)
41. A case of non-Hodgkin's lymphoma-associated pemphigus foliaceus and use of rituximab for treatment.
Prodanovic EM; Korman NJ
J Dermatolog Treat; 2008; 19(6):1-3. PubMed ID: 18720187
[TBL] [Abstract][Full Text] [Related]
42. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
[TBL] [Abstract][Full Text] [Related]
43. Thrombospondin-1 (TSP-1) and Survivin (S) expression in non-Hogkin's lymphomas.
Paydas S; Ergin M; Erdogan S; Seydaoglu G; Yavuz S; Disel U
Leuk Res; 2008 Feb; 32(2):243-50. PubMed ID: 17706282
[TBL] [Abstract][Full Text] [Related]
44. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM
Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841
[TBL] [Abstract][Full Text] [Related]
45. GM1 expression of non-Hodgkin's lymphoma determines susceptibility to rituximab treatment.
Meyer zum Büschenfelde C; Feuerstacke Y; Götze KS; Scholze K; Peschel C
Cancer Res; 2008 Jul; 68(13):5414-22. PubMed ID: 18593944
[TBL] [Abstract][Full Text] [Related]
46. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
47. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Al-Ali HK; Wittekind C; Niederwieser D
Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
[TBL] [Abstract][Full Text] [Related]
48. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
[TBL] [Abstract][Full Text] [Related]
49. Reduced expression of FLIP SHORT in bone marrow of low risk myelodysplastic syndrome.
de Melo Campos P; Traina F; da Silva Santos Duarte A; Lorand-Metze I; Costa FF; Saad ST
Leuk Res; 2007 Jun; 31(6):853-7. PubMed ID: 17270269
[TBL] [Abstract][Full Text] [Related]
50. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
[TBL] [Abstract][Full Text] [Related]
51. Topoisomerase IIalpha expression as an independent prognostic factor in Hodgkin's lymphoma.
Doussis-Anagnostopoulou IA; Vassilakopoulos TP; Thymara I; Korkolopoulou P; Angelopoulou MK; Siakantaris MP; Kokoris SI; Dimitriadou EM; Kalpadakis C; Matzouranis M; Kaklamanis L; Panayiotidis P; Kyrtsonis MC; Androulaki A; Patsouris E; Kittas C; Pangalis GA
Clin Cancer Res; 2008 Mar; 14(6):1759-66. PubMed ID: 18347177
[TBL] [Abstract][Full Text] [Related]
52. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
[TBL] [Abstract][Full Text] [Related]
53. [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma].
Huang HQ; Pan ZH; Lin XB; Wang BF; Hou JH; Zhang Y; Wu QL
Ai Zheng; 2006 Dec; 25(12):1517-23. PubMed ID: 17166378
[TBL] [Abstract][Full Text] [Related]
54. Apoptosis, vascularity, and proliferation in primary central nervous system lymphomas (PCNSL): a histopathological study.
Roser F; Saini M; Meliss R; Ostertag H; Samii M; Bellinzona M
Surg Neurol; 2004 Nov; 62(5):393-9; discussion 399. PubMed ID: 15518841
[TBL] [Abstract][Full Text] [Related]
55. Tissue expression of interleukin 2 (IL-2) and IL-2 receptor (IL-2R(alpha)/CD25) in non-Hodgkin B-cell lymphomas in children: correlations with clinical data.
Kasprzak A; Spachacz R; Wachowiak J; Stefańska K; Kaczmarek E; Zabel M
J Pediatr Hematol Oncol; 2010 Aug; 32(6):462-71. PubMed ID: 20562654
[TBL] [Abstract][Full Text] [Related]
56. Apoptotic index from fine needle aspiration cytology as a criterion to predict histologic grade of non-Hodgkin's lymphoma.
Symmans WF; Cangiarella JF; Symmans PJ; Cohen JM; Yee HT; Bennett G; Amorosi EL; Waisman J
Acta Cytol; 2000; 44(2):194-204. PubMed ID: 10740606
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of cFLIP in head and neck squamous cell carcinoma and its clinicopathologic correlations.
Li X; Pan X; Zhang H; Lei D; Liu D; Xu F; Luan X
J Cancer Res Clin Oncol; 2008 May; 134(5):609-15. PubMed ID: 17922291
[TBL] [Abstract][Full Text] [Related]
58. Expression of cellular FLICE inhibitory proteins (cFLIP) in normal and traumatic murine and human cerebral cortex.
Hainsworth AH; Bermpohl D; Webb TE; Darwish R; Fiskum G; Qiu J; McCarthy D; Moskowitz MA; Whalen MJ
J Cereb Blood Flow Metab; 2005 Aug; 25(8):1030-40. PubMed ID: 15815586
[TBL] [Abstract][Full Text] [Related]
59. Fas, Fas-associated death domain-like interleukin 1beta-converting enzyme-like inhibitory protein, and apoptotic features of elderly acute myeloid leukemia based on response to induction chemotherapy.
Kim HJ; Park BH; Choi Y; Min WS; Lee JW; Kim CC
Int J Hematol; 2005 Nov; 82(4):327-32. PubMed ID: 16298825
[TBL] [Abstract][Full Text] [Related]
60. High expression of cathepsin D in non-Hodgkin's lymphomas negatively impacts on clinical outcome.
Nicotra G; Manfroi F; Follo C; Castino R; Fusco N; Peracchio C; Kerim S; Valente G; Isidoro C
Dis Markers; 2010; 28(3):167-83. PubMed ID: 20534902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
